GovChime
Notice ID: dfbaa2b6d1c04cc8865415be876e6138Award NoticeAwarded

Development of a VesiVax� HIV Vaccine Formulation

Awarded on July 1, 2021. The description is published on SAM.gov: Full description on SAM.gov.

Awarded tounder 75N93021C00027 (source: SAM.gov award notice)• $2.3M

Overview

Posted
July 2, 2021
Notice type
Award Notice
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
NAICS 54171 Research and Development in the Physical, Engineering, and Life Sciences (reported as 541710)

Notice details

Place of performance
Rancho Dominguez, CA, 90220
Last updated
Dec 4, 2025
Award date
Jul 1, 2021
Award amount (SAM.gov award notice)
$2.3M

Identifiers

Solicitation number
PHS2021-1
Notice ID
dfbaa2b6d1c04cc8865415be876e6138
Award number (PIID)
75N93021C00027

Description

No description in the SAM.gov data feed for this notice.

Full description on SAM.gov

Award Overview

Award Number

75N93021C00027

Award Amount (SAM.gov award notice)

$2.3M

Award Date

Jul 1, 2021

Awardee

Awardee UEI

R1JMHFESEKD5

Original Solicitation

Notice ID: dfbaa2b6d1c04cc8865415be876e6138

Posted Date: Jul 2, 2021

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

2
  • 75N93024C00018
    MOLECULAR EXPRESS, INC
    Department of Health and Human ServicesNAICS 541715
    $2.0MSigned Jun 2, 2026
  • 75N93023C00033
    MOLECULAR EXPRESS, INC
    Department of Health and Human ServicesNAICS 541715
    $599.9KSigned Apr 10, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:PHS2021-1
  1. Awarded

This opportunity has been awarded.

  1. 3×
    AwardedCurrentJul 2, 2021

    Development of a VesiVax� HIV Vaccine Formulation

    Notice dfbaa2b6d1c04cc8865415be876e6138 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

PHS2021-1

Archive Date

Jul 16, 2021

Office Address

BETHESDA, MD, 20892